Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
See Latest ArticlesAnalysis of mutations in TP53, APC, K-ras, and DCC genes in the non-dysplastic mucosa of patients with inflammatory bowel disease
International Journal of Colorectal Disease, 06/23/09
Carvalho ATP et al. - Mutations in APC gene may occur in the non-dysplastic CD mucosa of patients with disease for more than 10 years. The follow-up of these patients will show the likelihood of mutant APC progressing to CRC in CD. Further analysis will be required for evaluating the impact of these findings in the context of cancer surveillance in inflammatory bowel disease.
Related Articles
Do Non-steroidal Anti-inflammatory Drugs Cause Exacerbations of Inflammatory Bowel Disease
Digestive Diseases and Sciences, 11/24/09
Relevance Score: 83%
Novel Diagnostic and Prognostic Modalities in Inflammatory Bowel Disease
Gastroenterology Clinics of North America, 11/24/09
Relevance Score: 83%
Pregnancy and Inflammatory Bowel Disease
Gastroenterology Clinics of North America, 11/17/09
Relevance Score: 83%
Pathogenesis of inflammatory bowel disease (IBD)
The Internet Journal of Gastroenterology, 11/13/09
Relevance Score: 83%
Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study
The Lancet, 11/09/09
Relevance Score: 83%
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
The 5-HT4 receptor agonist mosapride attenuates NSAID-induced gastric mucosal damage
Journal of Gastroenterology, 12/16/09
The complement component C3a fragment is a potential biomarker for hepatitis C virus-related hepatocellular carcinoma
Journal of Gastroenterology, 12/16/09
Comparison of HCV-associated gene expression and cell signaling pathways in cells with or without HCV replicon and in replicon-cured cells
Journal of Gastroenterology, 12/16/09
Today in Inflammatory Bowel Dz...keeping you current
Receive free subspecialty "5-minute updates" via email
Lethal neuroendocrine carcinoma in ulcerative colitis
World Journal of Gastroenterology, 12/16/09
Clinical outcome of newly diagnosed Crohns disease: a comparative, retrospective study before and after infliximab availability
Alimentary Pharmacology and Therapeutics, 12/16/09
Anti-fibrotic agents for the treatment of Crohn's disease - lessons learnt from other diseases
Alimentary Pharmacology and Therapeutics, 12/16/09
Sponsor
Article Search
Sponsor
Sponsor